Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 2Terminated 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER × epigallocatechin gallate × Clear all
NCT01311869 2013-10-24

Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids

Meharry Medical College

Phase 2 Terminated
43 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡